<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS191297</article-id><article-id pub-id-type="doi">10.1101/2023.11.16.567242</article-id><article-id pub-id-type="archive">PPR760971</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Molecular mechanisms of re-emerging chloramphenicol susceptibility in extended-spectrum beta-lactamase producing Enterobacterales</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Graf</surname><given-names>Fabrice E</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Goodman</surname><given-names>Richard N</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Gallichan</surname><given-names>Sarah</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Forrest</surname><given-names>Sally</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Picton-Barlow</surname><given-names>Esther</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fraser</surname><given-names>Alice J</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Phan</surname><given-names>Minh-Duy</given-names></name><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A4">4</xref><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Mphasa</surname><given-names>Madalitso</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Hubbard</surname><given-names>Alasdair T M</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>Musicha</surname><given-names>Patrick</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Schembri</surname><given-names>Mark A</given-names></name><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A4">4</xref><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Roberts</surname><given-names>Adam P</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Edwards</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Lewis</surname><given-names>Joseph M</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A6">6</xref><xref ref-type="aff" rid="A8">8</xref></contrib><contrib contrib-type="author"><name><surname>Feasey</surname><given-names>Nicholas A</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A6">6</xref><xref ref-type="aff" rid="A9">9</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK</aff><aff id="A2"><label>2</label>Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK</aff><aff id="A3"><label>3</label>Institute for Molecular Bioscience (IMB), The University of Queensland, Brisbane, Queensland, Australia</aff><aff id="A4"><label>4</label>School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia</aff><aff id="A5"><label>5</label>Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia</aff><aff id="A6"><label>6</label>Malawi-Liverpool Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi</aff><aff id="A7"><label>7</label>Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham, UK</aff><aff id="A8"><label>8</label>Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK</aff><aff id="A9"><label>9</label>School of Medicine, University of St Andrews, St Andrews, UK</aff><author-notes><corresp id="CR1">Correspondence: <email>fabrice.graf@lstmed.ac.uk</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>18</day><month>11</month><year>2023</year></pub-date><pub-date pub-type="preprint"><day>16</day><month>11</month><year>2023</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">Infections with Enterobacterales (E) are increasingly difficult to treat due to antimicrobial resistance. After ceftriaxone replaced chloramphenicol (CHL) as empiric therapy for suspected sepsis in Malawi in 2004, ESBL-E rapidly emerged. Concurrently, resistance to CHL in <italic>Escherichia coli</italic> and <italic>Klebsiella</italic> spp. decreased, raising the possibility of CHL re-introduction. However, many phenotypically susceptible isolates still carry CHL acetyltransferase (CAT) genes.</p><p id="P2">We used a combination of genomics, phenotypic susceptibility assays, experimental evolution and functional assays for CAT activity to understand the molecular mechanisms and stability of this re-emerging CHL susceptibility.</p><p id="P3">Of 840 Malawian isolates, 31% had discordant CHL susceptibility genotype-phenotype, and we selected 42 isolates for in-depth analysis. Stable degradation of <italic>cat</italic> genes by insertion sequences led to re-emergence of CHL susceptibility. Our study suggests CHL could be reintroduced as reserve agent for critically ill patients with ESBL-E infections in Malawi and similar settings and highlights the ongoing challenges in inferring antimicrobial resistance from sequence data.</p></abstract><kwd-group><kwd>AMR</kwd><kwd>resistance</kwd><kwd>acetyltransferase</kwd><kwd>IS<italic>26</italic></kwd><kwd>IS<italic>5</italic></kwd><kwd>mobile genetic element</kwd><kwd><italic>E. coli, Klebsiella</italic></kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P4">Antimicrobial resistance (AMR) is a major threat to global health. Drug resistant bacterial infections were estimated to be associated with 4.95 million deaths in 2019, with sub-Saharan Africa the worst affected region [<xref ref-type="bibr" rid="R1">1</xref>]. Among the most problematic drug resistant bacteria are extended-spectrum beta-lactamase (ESBL) producing Enterobacterales (E) which are resistant to 3<sup>rd</sup>-generation cephalosporins (3GC) and classified as priority pathogens by the WHO [<xref ref-type="bibr" rid="R2">2</xref>]. ESBL-E infections are associated with higher morbidity, mortality and economic burden in the treatment of bloodstream infections in Malawi [<xref ref-type="bibr" rid="R3">3</xref>, <xref ref-type="bibr" rid="R4">4</xref>], and in low resource settings such as Malawi access to effective treatment alternatives (e.g. carbapenems, or beta-lactam/beta-lactamase inhibitor combinations) is often lacking. The prevalence of ESBL-E rapidly increased in Malawi after ceftriaxone replaced chloramphenicol (CHL) as a first-line empiric therapy for suspected sepsis from 2004 [<xref ref-type="bibr" rid="R5">5</xref>, <xref ref-type="bibr" rid="R6">6</xref>].</p><p id="P5">CHL is an inhibitor of protein synthesis and broad-spectrum antibiotic discovered in 1947 [<xref ref-type="bibr" rid="R7">7</xref>], which is now rarely used, primarily because of the risk of severe adverse effects [<xref ref-type="bibr" rid="R8">8</xref>]. These include dose-unrelated aplastic anaemia, which is irreversible and fatal [<xref ref-type="bibr" rid="R9">9</xref>] but rare (incidence between 1:19,000 – 1:270,000 [<xref ref-type="bibr" rid="R10">10</xref>]), dose-related, reversible bone marrow suppression [<xref ref-type="bibr" rid="R11">11</xref>] and Grey Baby Syndrome [<xref ref-type="bibr" rid="R12">12</xref>]. As effective and safer broad-spectrum beta-lactam antibiotics were introduced, they replaced CHL in most settings. The dominant mechanism of CHL resistance is mediated by CHL acetyltransferases (CAT) inactivating CHL by acetylation [<xref ref-type="bibr" rid="R13">13</xref>]. Other mechanisms include efflux pumps, inactivation by phosphotransferases, target site mutations and decreased membrane permeability [<xref ref-type="bibr" rid="R13">13</xref>].</p><p id="P6">While resistance to 3GCs, fluoroquinolones and aminoglycosides increased in Malawi, resistance to CHL decreased as its use declined [<xref ref-type="bibr" rid="R5">5</xref>]. <italic>Escherichia coli</italic> and <italic>Klebsiella pneumoniae</italic> populations showed decreasing proportions of CHL resistant isolates, from around 80% in 1998-2004 to around 50% and below from 2012, sparking an interest in whether CHL can be re-introduced as a treatment option for ESBL-E infections in critically ill patients where there is no alternative therapy [<xref ref-type="bibr" rid="R5">5</xref>, <xref ref-type="bibr" rid="R14">14</xref>]. Some bacteria isolated in Malawi, however, have a discordant CHL genotype-phenotype, i.e. they still harbour CHL resistance genes despite being phenotypically susceptible [<xref ref-type="bibr" rid="R15">15</xref>–<xref ref-type="bibr" rid="R18">18</xref>]. Therefore, simple CHL resistance gene loss caused, for example, by lineage or plasmid replacement in the bacterial population is unlikely. With the prospect of using CHL as a potential reserve agent for 3GC resistant infections it is important to understand (i) the molecular mechanism(s) of this re-emerging CHL susceptibility, i.e., the molecular basis of CHL susceptibility genotype-phenotype mismatches, (ii) the stability of the phenotypic susceptibility and (iii) how widespread this phenomenon is.</p><p id="P7">Here, we investigated a collection of ESBL <italic>E. coli</italic> and <italic>K. pneumoniae</italic> with CHL susceptibility genotype-phenotype mismatches. Using functional assays in combination with genomic data, we determined the CHL sensitivities, CAT enzyme activity, and functional expression of <italic>cat</italic> genes, to understand the molecular mechanism of re-emerging CHL susceptibility. Further, we tested the stability of CHL susceptibility in several isolates employing experimental evolution with increasing concentrations of CHL and used co-occurrence analysis of AMR genes and investigated the spread of <italic>cat</italic> alleles in the context of sequence types to identify potential drivers to explain the high proportion of CHL susceptibility in ESBL-E populations in Malawi.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Genotype-phenotype mismatch for chloramphenicol resistance</title><p id="P8">We screened a collection of 566 <italic>E. coli</italic> and 274 <italic>K. pneumoniae</italic> species complex <italic>(KpSC)</italic> isolates previously isolated from patients admitted to Queen Elizabeth Central Hospital (QECH) in Blantyre, Malawi. All isolates had been whole-genome sequenced, of which 164 (93 <italic>E. coli</italic>, 71 <italic>KpSC</italic>) were from sentinel surveillance of bacteraemia [<xref ref-type="bibr" rid="R5">5</xref>, <xref ref-type="bibr" rid="R15">15</xref>, <xref ref-type="bibr" rid="R16">16</xref>] and 676 isolates (473 <italic>E. coli</italic>, 203 <italic>KpSC)</italic> were asymptomatically carried ESBL-isolates from stool, collected in a research study [<xref ref-type="bibr" rid="R14">14</xref>, <xref ref-type="bibr" rid="R17">17</xref>, <xref ref-type="bibr" rid="R18">18</xref>] (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>). Of the total isolates, 53.5% (449/840) were phenotypically susceptible to CHL (<xref ref-type="fig" rid="F1">Fig. 1a</xref>) and 31.0% (260/840) had a discordant genotype-phenotype. 45.0% of phenotypically susceptible isolates (202/449) harboured CHL resistance genes; the majority were chloramphenicol acetyltransferase <italic>(cat)</italic> genes (193/202) (<xref ref-type="fig" rid="F1">Fig. 1b</xref>). The most prevalent <italic>cat</italic> genes were <italic>catB4</italic> (229) followed by <italic>catA1</italic> (189), <italic>catA2</italic> (104) and <italic>catB3</italic> (19) (<xref ref-type="fig" rid="F1">Fig. 1c</xref>). Other known CHL resistance genes, <italic>cmlA1</italic> (29)<italic>, cmlA5</italic> (23) and <italic>floR</italic> (14), were less common in the collection. We selected a subset of 42 isolates, 27 <italic>E. coli</italic> (13 CHL-R, 14 CHL-S) and 15 <italic>K. pneumoniae</italic> (6 CHL-R, 9 CHL-S), based on a genotype-phenotype mismatch and control isolates (same sequence type (ST) if available) for further in-depth functional analysis (<xref ref-type="table" rid="T1">Table 1</xref>) to investigate the molecular mechanism of those mismatches. First, we determined the CHL susceptibility for each isolate by broth microdilution and compared the result to previously collected AST data [<xref ref-type="bibr" rid="R5">5</xref>, <xref ref-type="bibr" rid="R14">14</xref>], determined for CHL using the disc diffusion method. For 81.0 % (34/42) isolates, microbroth dilution confirmed the result of disc testing and we concluded that phenotype-genotype mismatches were not explained by inaccurate phenotypic data. Five of the eight isolates that had discordant disc diffusion and MIC results were within 2x of the breakpoint for CHL (&gt;8 μg/mL) <xref ref-type="table" rid="T1">Table1</xref>. We used the more sensitive MIC result to classify isolates as resistant or susceptible.yt</p></sec><sec id="S4"><title>No CAT activity in susceptible isolates</title><p id="P9">Next, we tested all 42 isolates for CAT enzyme activity to determine whether <italic>cat</italic> genes were functionally expressed. We adapted the rapid CAT assay (rCAT) [<xref ref-type="bibr" rid="R19">19</xref>] as an indirect measure of enzyme activity. The rCAT assay measures free sulfhydryl groups of the CAT substrate and acetyl donor acetyl-coenzyme A in cell lysates and a colour change to yellow indicating CAT enzyme activity can be spectrophotometrically measured.</p><p id="P10">All phenotypically CHL-S isolates, irrespective of the presence of a <italic>cat</italic> gene, were negative for CAT activity (<xref ref-type="fig" rid="F2">Fig. 2</xref>). All but five resistant isolates (CAC10A, CAC122, CAC10H, CAB119, CAC13Y) with a <italic>cat</italic> gene showed CAT activity. Three CHL-R/rCAT negative isolates carried <italic>catB4</italic> genes and this was the only <italic>cat</italic> gene present. Isolate CAB199 (CHL MIC = 128 μg/mL) co-carried a <italic>floR</italic> gene which could contribute to the CHL-R phenotype. Isolates CAC13Y (CHL MIC = 64 μg/mL) and CAC10H (CHL MIC = 16 μg/mL) had no other detectable CHL resistance determinants whereas CAC10A had a <italic>catA1</italic> but a weak CHL-R phenotype (MIC = 16 μg/mL). We used the disc-diffusion (dCAT) assay [<xref ref-type="bibr" rid="R20">20</xref>] as a secondary and independent assay, which is based on the ability of CAT producing bacteria to cross-protect susceptible bacteria by inactivating CHL. Tested isolates (CAB119, CAC13Y) failed to cross-protect a sensitive strain, thus confirming that <italic>catB4</italic> in those isolates is non-functional (<xref ref-type="supplementary-material" rid="SD1">supplementary Fig. 1</xref>). One isolate (CAC122) that carried <italic>cat_pC221</italic>, a <italic>cat</italic> gene originating from <italic>Staphylococcus aureus</italic> [<xref ref-type="bibr" rid="R21">21</xref>], did not show enzyme activity and its resistance phenotype is likely explained by <italic>cmlA1.</italic> This <italic>cat</italic> gene was shown to be inducible and regulated through translational attenuation [<xref ref-type="bibr" rid="R22">22</xref>]; we thus tested this isolate with sub-MIC concentration of CHL in culture media but no CAT activity was observed. We concluded that resistant isolates with <italic>catA1, catA2</italic> and <italic>catB3</italic> have functional CATs whereas isolates with <italic>catB4</italic> do not. Phenotypically susceptible isolates with or without <italic>cat</italic> genes did not show CAT activity demonstrating that <italic>cat</italic> genes in those CHL-S isolates are not expressed.</p></sec><sec id="S5"><title>Functional expression of <italic>catB4</italic> does not confer CHL resistance</title><p id="P11">To assess the effect of the genetic context of <italic>cat</italic> genes in our isolates, we cloned the coding sequence (CDS) of the dominant <italic>cat</italic> variants present in the collection <italic>(catA1, catA2, catB3</italic> and <italic>catB4)</italic> into the expression vector <italic>pEB1-sfGFP</italic> [<xref ref-type="bibr" rid="R23">23</xref>] under the constitutive <italic>proC</italic> promoter, by replacing <italic>sfGFP</italic>, and tested their susceptibility to CHL in a clean genetic background of <italic>E. coli</italic> MG1655. MG1655 pEB1-<italic>catB4</italic> had an MIC of 8 μg/mL identical to the MG1655 pEB1-sGFP control whereas all other <italic>cat</italic> variants had an MIC of &gt;512 μg/mL confirming that <italic>catB4</italic> is a non-functional variant (<xref ref-type="table" rid="T1">Table 1</xref>).</p></sec><sec id="S6"><title><italic>catB4</italic> is a non-functional truncated <italic>catB3</italic></title><p id="P12">Functional CAT assays (rCAT and dCAT) demonstrated that <italic>catB4</italic> in the genetic context of tested isolates was non-functional and ectopic expression of <italic>catB4</italic> confirmed that the CDS does not produce a functional product that confers CHL resistance. We previously observed that in addition to a full length assembled <italic>catB4</italic> (549 bp) many isolates had several partial assemblies in their genomes of approximately 107 bp (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 2a</xref>, [<xref ref-type="bibr" rid="R24">24</xref>]). We investigated the 107 bp (position 443-549 of <italic>catB4)</italic> by BLASTn against NCBI’s nucleotide collection and obtained many hits among different Enterobacterales with 100% query cover and sequence identity matching the “IS<italic>6</italic>-like element IS<italic>26</italic> family transposase”. We next compared <italic>catB4</italic> with <italic>catB3</italic> by pairwise sequence alignment. Both CDS share 100% sequence identity for the first 442 bases and only differ after position 443, corresponding to the last 107 bp of <italic>catB4</italic> matching with the IS<italic>26</italic> sequences (<xref ref-type="fig" rid="F3">Fig. 3a</xref>). All but seven <italic>catB4</italic> assemblies in our isolate collection share 100% sequence identity (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 2b</xref>) with <italic>catB3</italic> but only until position 442 bp (full length <italic>catB3</italic> is 633 bp). Therefore, we concluded that <italic>catB4</italic> is a truncated variant of <italic>catB3</italic> and suggest it should be called <italic>catB3Δ<sup>443-633</sup>.</italic> IS<italic>26</italic>-mediated deletions of adjacent DNA have previously been reported [<xref ref-type="bibr" rid="R25">25</xref>, <xref ref-type="bibr" rid="R26">26</xref>].</p><p id="P13">We traced <italic>catB4</italic> back in the literature and found it was first described, to the best of our knowledge, in two plasmids (pEK499 and pEK516) [<xref ref-type="bibr" rid="R27">27</xref>]. Both plasmids had been moved into different <italic>E. coli</italic> lab strains and did not confer CHL resistance, consistent with our data showing that <italic>catB4</italic> is not a functional CAT. Because this had been annotated as <italic>catB4</italic> variant in the ARG-ANNOT (and SRST2) databases [<xref ref-type="bibr" rid="R28">28</xref>] we tested two additional databases for AMR genes. Both, the CARD database [<xref ref-type="bibr" rid="R29">29</xref>] and ResFinder [<xref ref-type="bibr" rid="R30">30</xref>] called the truncated <italic>catB3</italic> correctly.</p><p id="P14">We selected five <italic>E. coli</italic> isolates for long-read sequencing to investigate the genomic context of <italic>catB3Δ<sup>443-633</sup></italic> (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 3</xref>). Aligning four closed contigs containing <italic>catB3</italic> and its truncated variant showed a similar and common genetic feature of <italic>aac(6’)-Ib-cr</italic> - <italic>bla</italic><sub>oxA-1</sub>-<italic>catB3</italic> flanked by two IS<italic>26</italic> elements. There was an additional IS<italic>26</italic> downstream of the wild type <italic>catB3</italic> gene (<xref ref-type="fig" rid="F3">Fig. 3b</xref>). In the four isolates this feature is located on a different replicon, on the chromosome and three different IncF plasmids suggestive of moving as transposable element independent of a single plasmid-type. As this genetic feature has previously been shown to be part of an integron cassette [<xref ref-type="bibr" rid="R31">31</xref>, <xref ref-type="bibr" rid="R32">32</xref>], we ran IntegronFinder and found <italic>attC</italic> sites upstream of <italic>bla</italic><sub>oxA-1</sub> and downstream of <italic>catB3</italic>, however, the truncation of <italic>catB3</italic> removed the <italic>attC</italic> site, likely precluding its ability to move between or within integron(s). Further, the integrase gene is missing in all but one isolate (CAE137) where it is interrupted by IS<italic>26</italic> (<xref ref-type="fig" rid="F3">Fig. 3b</xref>).</p></sec><sec id="S7"><title>IS<italic>5</italic> insertion into <italic>catA1</italic> promoter causes reversal of CHL resistance</title><p id="P15">Of 9/42 isolates with a <italic>catA1</italic>, only four had a CHL resistance phenotype consistent with its genotype (<xref ref-type="fig" rid="F2">Fig. 2</xref>). We therefore PCR-probed these nine isolates with primers specific for <italic>catA1</italic> to confirm its presence. Three isolates containing <italic>catA1</italic> that were CHL-R had the expected amplicon size of 150 bp, however three CHL-S isolates and CAC10A had a larger amplicon than expected of ~1400 bp, (<xref ref-type="supplementary-material" rid="SD1">supplementary Fig. 3</xref>). We assembled the genomes of isolates with <italic>catA1</italic> and aligned the contigs containing <italic>catA1.</italic> Two contigs (from isolates CAI10X &amp; CAI10E) showed a presumed insertion of 1199 bp, starting 6 bp upstream of the CDS, matching the larger than expected PCR amplicon and BLASTn revealed a 100% match to an IS<italic>5</italic> element. In addition, we purified and Sanger-sequenced the ~1400 bp PCR product and confirmed the insert as an IS<italic>5</italic> element in three of the isolates. Long-read sequencing of isolate CAC10A confirmed the insertion of IS<italic>5</italic> as a single element into the promoter region of <italic>catA1</italic> (<xref ref-type="fig" rid="F3">Fig. 3c</xref>). Overall, of the isolates with <italic>catA1</italic>, 3/9 were CHL-R with detectible CAT activity (<xref ref-type="fig" rid="F2">Fig. 2</xref>) and had an expected <italic>catA1</italic> amplicon size (150bp); isolate CAC10A was CHL-R with an MIC close to the breakpoint (16 mg/L), no detectable CAT activity and IS<italic>5</italic> inserted into the <italic>catA1</italic> promoter region. The remainder (5/9) were CHL-S, without detectable activity on the rCAT assay; in 3/5 this was likely mediated by IS<italic>5</italic> insertion interfering with transcription.</p><p id="P16">We adjusted primers from a previously developed high-resolution melting (HRM) assay [<xref ref-type="bibr" rid="R33">33</xref>] to capture <italic>IS5-catA1</italic> and the truncated <italic>catB3Δ<sup>443-633</sup></italic>, and demonstrated that they can be clearly distinguished from the wild type genes (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 4</xref>), highlighting the potential of this molecular diagnostic test for CHL resistance to discriminate between functional and non-functional <italic>cat</italic> genes.</p></sec><sec id="S8"><title>Degradation of <italic>cat</italic> genes by insertion sequences is stable</title><p id="P17">IS<italic>5</italic> insertion into the promoter of <italic>catA1</italic> and truncation of <italic>catB3</italic> are the main mechanisms for the observed re-emerging CHL susceptibility in our collection of isolates. To test if these mutation and insertion events could be reversed and potentially result in a rapid re-emergence of <italic>cat</italic> expression and CHL resistance, we experimentally evolved three CHL susceptible isolates: CAI10Z <italic>(catA1, catB3Δ<sup>443-633</sup>)</italic>, CAM10K <italic>(catA1)</italic> and CAI10X <italic>(catA1)</italic> in LB broth with increasing concentrations of CHL for 7 days (n=3 per isolate). An equal number of replicates were evolved in LB without selection. All evolved populations under CHL selection grew until 64 μg/mL CHL (8-16 -fold increase in MIC). Increasing incubation for another 24 h enabled recovery of some populations in 128 μg/mL (i.e., clearly visible growth) but none of the CHL populations grew in 256 μg/mL CHL (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 5a</xref>). All control populations evolved in LB grew until the experiment was stopped at day 7. Since we were interested if CHL pressure can result in a re-activation of <italic>cat</italic> genes we tested all evolved populations with the rCAT assay (LB evolved from day 7, CHL evolved last surviving population, day 5, day 6 or day 7). All populations examined tested negative on the rCAT assay (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 5b</xref>) and PCR-probing of evolved strains showed that the IS<italic>5</italic> insertion was still present upstream of <italic>catA1</italic> (<xref ref-type="supplementary-material" rid="SD1">supplementary Fig. 5c</xref>), confirming that other mutations rather than (re-)expression of <italic>catA1</italic> are responsible for the resistance phenotype.</p></sec><sec id="S9"><title>The genomic locus of <italic>catB3Δ<sup>443-633</sup></italic> is conserved and widespread</title><p id="P18">The truncated <italic>catB3Δ<sup>443-633</sup></italic> is common among our isolates and seems to be highly conserved in the genomic context of <italic>aac</italic>(6’)-Ib-cr -<italic>bla</italic><sub>oxA-1</sub> - <italic>catB3.</italic> To investigate potential drivers, we ran a co-occurrence analysis across 772 genomes in our collection from Malawi (68 of the 840 total isolates failed assembly quality check) (<xref ref-type="supplementary-material" rid="SD1">Fig. S6</xref>, <xref ref-type="supplementary-material" rid="SD1">supplementary Table 4</xref>). We applied the probabilistic model from [<xref ref-type="bibr" rid="R34">34</xref>] to determine whether each pair of genes had an observed co-occurrence which was significantly different from the expected co-occurrence. The co-occurrence relationships across all AMR genes with at least one other gene is depicted in <xref ref-type="supplementary-material" rid="SD1">Fig. S6</xref>. Both, <italic>catB3</italic> and <italic>catB3Δ<sup>443-633</sup></italic> had a positive co-occurrence relationship with <italic>bla</italic><sub>oxA-1</sub> and <italic>aac(6’)-Ib-cr</italic> and the beta-lactamase genes <italic>bla</italic><sub>CTX-M-15</sub> and <italic>bla</italic><sub>TEM-1B</sub>. The <italic>catB3</italic> and <italic>catB3Δ<sup>443-633</sup></italic> genes had a negative co-occurrence as they were never found to co-occur on the same genome (<xref ref-type="fig" rid="F4">Fig. 4</xref>).</p><p id="P19">In our isolates, <italic>catB3Δ<sup>443-633</sup></italic> is much more common than <italic>catB3</italic>, and thus we investigated if this pseudogene is restricted to Malawi or common elsewhere. We queried “catB3” in NCBI’s Microbial Browser for Identification of Genetic and Genomic Elements (Micro-BIGG-E) [<xref ref-type="bibr" rid="R35">35</xref>] and investigated 46,667 isolates (data download: 4/8/2023) with an annotated <italic>catB3</italic> gene. Strikingly, 30,819 (66%) showed a coverage to the reference of 70%, which corresponds to the IS<italic>26</italic> truncated variant described here (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 7a</xref>). We tried to trace back the emergence of this truncation. From 2006 onwards (only including years with &gt; 100 isolates) the truncated variant was dominant over the wild type, and we could not conclude when it emerged (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 7b</xref>). <italic>Klebsiella</italic> spp., <italic>E. coli</italic> and <italic>Enterobacter</italic> spp. dominantly show the truncated gene whereas <italic>Salmonella, Acinetobacter</italic> and <italic>Pseudomonas</italic>, typically harbour wild type <italic>catB3</italic> (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 7c</xref>). Differentiating by host where the isolates have been collected is heavily biased towards humans where the dominant truncated variant is much more common. This is also seen in companion animals (cats and dogs) whereas in most food animals, the wild type proportion is close to 100%, perhaps indicative of ongoing selection for chloramphenicol resistance through use of phenicols in veterinary medicine and agriculture (<xref ref-type="supplementary-material" rid="SD1">supplementary Fig. 7d</xref>). Most geographic locations show higher proportions of the truncated variant with a few exceptions in China and Australia (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 7e</xref>).</p><p id="P20">Next, we investigated the spread of <italic>catB3Δ<sup>443-633</sup></italic> in the context of ST to potentially link clonal expansion and <italic>catB3Δ<sup>443-633</sup></italic> carried by these clones <italic>in E. coli.</italic> The <italic>catB3Δ<sup>443-633</sup></italic> gene was restricted to six STs (410, 44, 648, 405, 617, 131) in our Malawi isolates (<xref ref-type="fig" rid="F5">Fig. 5</xref>), and five of those STs are among the top 8 most common STs in our collection (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 8</xref>). We expanded our analysis and looked at a collection of 10k genomes consisting of the top 100 common STs in <italic>E. coli</italic> (previously curated and downloaded from Enterobase (2020)[<xref ref-type="bibr" rid="R36">36</xref>] where each ST was randomly sampled to select 100 genomes. All six STs with <italic>catB3Δ<sup>443-633</sup></italic> in Malawi also dominantly harbour this <italic>cat</italic> gene in this extended genome collection (<xref ref-type="fig" rid="F5">Fig. 5</xref>). In phylogroup B2 (predominantly human isolates associated with urinary tract and bloodstream infections) <italic>catB3Δ<sup>443-633</sup></italic> is common in ST131 and to a lesser extend ST1193 (<xref ref-type="fig" rid="F5">Fig. 5</xref>), both of which represent recently emerged globally dominant antibiotic resistant clones [<xref ref-type="bibr" rid="R37">37</xref>, <xref ref-type="bibr" rid="R38">38</xref>]. The ubiquitousness of <italic>catB3Δ<sup>443-633</sup></italic> may thus be linked to its association with distinct and successful lineages.</p></sec></sec><sec id="S10" sec-type="discussion"><title>Discussion</title><p id="P21">In Malawi, as in much of sub-Saharan Africa, the rapid spread of ESBL-E coupled with the scarcity of Watch and Reserve antibiotics (i.e. carbapenems) has rendered many severe bacterial infections untreatable, therefore the re-emergence of chloramphenicol susceptibility is potentially important. 34.2% (1666/4874) of non-salmonella Enterobacterales were phenotypically CHL susceptible in bloodstream infections in Malawi from 1998-2016 [<xref ref-type="bibr" rid="R5">5</xref>]. Here, we analysed a collection of phenotypically and genotypically characterised <italic>E. coli</italic> and <italic>KpSC</italic> from Malawi to understand the molecular basis of CHL-S genotype-phenotype mismatches.</p><p id="P22">Since many phenotypically susceptible isolates in our collection carried <italic>cat</italic> genes, we first investigated if they were still functional and expressed. None of the CHL-S isolates we tested had functional CATs and we found that <italic>cat</italic> gene interruption was caused by insertion sequences. This is in contrast to a previous study reporting an <italic>E. coli</italic> strain being susceptible to CHL despite a functional CAT [<xref ref-type="bibr" rid="R39">39</xref>] which was later attributed to low level of acetyl-coenzyme A linked to mutations in efflux pumps [<xref ref-type="bibr" rid="R40">40</xref>]. Combined functional analysis of <italic>catB4</italic> with a CAT enzyme assays, expression in a clean genetic background as well as genomic investigation confirmed that <italic>catB4</italic> is non-functional and is in fact a <italic>catB3</italic> that has been truncated by an IS<italic>26</italic> element. In other cases, an IS<italic>5</italic> element has integrated into the promoter region of <italic>catA1</italic> and likely interfered with transcription. In the latter case, calling AMR genes from all databases with sequence data will yield a wild type gene and currently classify the isolate as resistant since the mutation is outside of the CDS. The truncated <italic>catB3</italic> will be called correctly if the annotation of <italic>catB4</italic> is removed in the ARG-ANNOT/SRST2 databases, which we strongly support.</p><p id="P23">To effectively re-introduce CHL as a reserve treatment option for Enterobacterales infections confirmed as 3GC-resistant, we must consider the potential for reversion to CHL-resistance. Isolates carrying <italic>IS5-catA1</italic> could potentially rapidly revert to high-level resistance since the <italic>catA1</italic> CDS is still present in the genome. Our data using experimental evolution suggest that this is not the case and selection with CHL did not lead to expression of <italic>catA1.</italic> One of the evolved isolates co-carried a truncated <italic>catB3</italic> and we expected no reversion to a functional <italic>catB3</italic> upon CHL selection because the missing 3’ prime end of the gene is no longer present in the genome. Indeed, no functional <italic>cat</italic> emerged.</p><p id="P24">A decrease in CHL resistant isolates has also been reported for <italic>Salmonella</italic> Typhimurium, which was caused via loss of CHL resistance genes by lineage replacement [<xref ref-type="bibr" rid="R41">41</xref>]. Our study adds to a developing evidence base for CHL in treatment of MDR Gram-negative pathogens; several studies have reported high or increasing rates of phenotypic CHL susceptibility among MDR Gram-negative bacteria suggesting CHL as a viable alternative treatment option in those settings [<xref ref-type="bibr" rid="R42">42</xref>–<xref ref-type="bibr" rid="R44">44</xref>]. Further, CHL is an affordable and useful antimicrobial in terms of bioavailability, tissue penetration and broad spectrum of action [<xref ref-type="bibr" rid="R45">45</xref>, <xref ref-type="bibr" rid="R46">46</xref>]. However, the prevalence of CHL susceptibility and the rare but severe side-effects of CHL, preclude the use of CHL for empirical management of sepsis in our setting: we instead envisage CHL to be used in critically ill patients with confirmed ESBL-E and CHL-S infection as a reserve agent. This has the added advantage of keeping selection pressure for CHL resistance low but does require rapid determination of CHL susceptibility phenotype.</p><p id="P25">In the Malawian isolates the gold-standard AST correctly determined phenotypic CHL susceptibility, however, rapid molecular diagnostics have the potential to be faster and low cost. We applied the HRM assay to distinguish between the <italic>cat</italic> mutants found in our study.</p><p id="P26">Co-occurrence analysis showed that <italic>catB3</italic> and <italic>catB3Δ<sup>443-633</sup></italic> nearly always co-occurred with <italic>aac(6’)-Ib-cr</italic> and <italic>bla</italic><sub>oxA-1</sub>. This conserved feature of <italic>aac</italic>(6’)-Ib-cr-<italic>bla</italic><sub>oxA-1</sub>-catB flanked by IS<italic>26</italic>, which was confirmed by long-read sequencing, has previously been associated with an integron [<xref ref-type="bibr" rid="R32">32</xref>] and was found to contain <italic>attC</italic> sites when <italic>catB3</italic> was present. However, the truncation by IS<italic>26</italic> removed one of the <italic>attC</italic> sites. This, in combination with loss of the integrase gene, likely led to functional loss of mobilisation of genes within the integron and the high conservation of this locus is confirmatory. The association of <italic>catB3Δ<sup>443-633</sup></italic> with <italic>bla</italic><sub>CTX</sub>-M-15, the most common ESBL gene found in <italic>E. coli</italic> isolates worldwide [<xref ref-type="bibr" rid="R47">47</xref>] and among our Malawian isolates [<xref ref-type="bibr" rid="R17">17</xref>, <xref ref-type="bibr" rid="R18">18</xref>], may point towards the co-location of these genes on a plasmid, though a larger selection of isolates will need to be (long-read) sequenced to determine the spread of such a plasmid. Selection for 3GC resistance and co-occurring <italic>bla</italic><sub>CTX</sub>-M-15 with <italic>catB3Δ<sup>443-633</sup></italic> could have led to a genetic hitchhiking of the latter which could explain the high levels of CHL susceptible isolates among ESBLs. However, our isolate collection is heavily biased towards ESBL and may thus limit the interpretation of this co-occurrence.</p><p id="P27">Expanding our analysis of <italic>catB3Δ<sup>443-633</sup></italic> revealed that this single truncation is globally more common than the wild type gene. It is intriguing that a truncated non-functional gene is so widespread, and we hypothesise this is due to the specific genetic context of a loss of integron activity, and association with other AMR genes as well as with IS<italic>26</italic>. It has previously been shown that IS<italic>26</italic> and pseudo-compound transposons (i.e. IS<italic>26</italic> bounded transposons) move 50x more frequently if there is another IS<italic>26</italic> to target [<xref ref-type="bibr" rid="R48">48</xref>] and move by co-integration [<xref ref-type="bibr" rid="R49">49</xref>].</p><p id="P28">This mode of mobility likely enhances persistence. Additionally, association of <italic>catB3Δ<sup>443-633</sup></italic> with globally dominant lineages of <italic>E. coli</italic> (e.g. ST131) as seen in our ST analysis, could be a likely driver that has contributed to the widespread occurrence of this truncated variant.</p><p id="P29">Our study highlights that antibiotic susceptibility can re-emerge following a reduction or cessation in use. Plasticity and the high levels of horizontal gene transfer among Enterobacterales can result in degradation of AMR genes by mobile genetic elements which can persist in the absence of selection. Further, the context of the AMR gene determines the phenotypic resistance and database curation is crucial to infer resistance from the genotypes. We strongly recommend integrating functional context to databases and including additional features such as genetic context, including promoters and transcription start site. Many AMR genes only cause clinically relevant resistance when they are moved to locations in the genome where expression is upregulated, such as downstream of a strong promoter [<xref ref-type="bibr" rid="R50">50</xref>]. This is problematic with functional metagenomic discovery of AMR genes since the mere presence of an AMR gene is not indicative of phenotypic resistance. Lastly, our data support the reintroduction of CHL as a last-line treatment option for patients critically ill with ESBL-E infections in Malawi and similar settings.</p></sec><sec id="S11" sec-type="materials | methods"><title>Materials and methods</title><sec id="S12"><title>Antimicrobial susceptibility testing</title><p id="P30">AST was performed using broth microdilution according the EUCAST guidelines (v.4.0) in cation adjusted MullerHinton broth (MH2, 90922, Merck) in duplicates. If results were inconsistent or different to the CHL susceptibility phenotype previously determined with disc diffusion, AST was repeated. Broth microdilution data was used to determine the phenotypic classification of the subset of 42 isolates. Isolate are classified according to EUCAST (v.12.0); isolates with an MIC ≤ 8 μg/mL were classified as susceptible and isolates &gt; 8 μg/mL as resistant. In EUCAST v.13.0, CHL breakpoints are no longer listed, stating a screening cut-off (CHL MIC &gt; 16 μg/mL) can be used to distinguish wild type from acquired resistance.</p></sec><sec id="S13"><title>Functional CAT assay (rCAT)</title><p id="P31">We adjusted the rapid CAT assay from [<xref ref-type="bibr" rid="R19">19</xref>] to enable read-out in 96-well plates using a spectrophotometer. Cultures of isolates to be tested were set up in replicates in 1-2 mL LB and incubated at 37 °C with 220 rpm. 100 μL of overnight culture was transferred into a microcentrifuge tube containing 500 μL PBS and centrifuge at 8000 rpm for 3’ to wash and pellet cells. The supernatant was completely removed using a pipette, the pellet resuspended in 250 μL lysis buffer (1 M NaCl, 0.01 M EDTA, 0.05 % SDS) and cells lysed while incubating for 1 h at 37 °C with occasionally vortexing the tubes. Next, 50 μL of the lysed cells were transferred into each of 4 wells of a 96-well plate. To each well 50 μL reaction buffer was added (for 1 mL, 400 μL 0.2 M Tris; 400 μL 5 mM acetyl-coA; 200 μL 10 mM DTNB were mixed). DTNB was added last to the wells, since DTNB was reported to inhibit certain CAT enzymes [<xref ref-type="bibr" rid="R19">19</xref>]. DTNB was always prepared fresh since stored DTNB (for even 1 day at 4 °C in the dark) increased the background. Acetyl-coA was always prepared on ice and aliquots immediately frozen at -20 °C and used within 2 weeks.</p><p id="P32">50 μL 5 mM CHL was added to the first two wells and 50 μL ddH<sub>2</sub>O to the wells three and four of each isolate. The plate was incubated for &gt; 10 min at 37 °C - longer incubation led to a higher signal for positive samples while the background did not change - up to 1 hour tested. The plate was read with a plate reader (GloMax® Discover Microplate Reader (Promega) or CLARIOstar Plus Microplate Reader (BMG Labtech)) at absorbance of 405 nm or 412 nm and absorption from lysed cells without CHL was subtracted from the value with CHL, hence, positive values indicate CAT activity, no activity give a value around zero.</p></sec><sec id="S14"><title>Chemical competent cells and transformation</title><p id="P33">MG1655 were made chemically competent as follows: A single colony of MG1655 was picked from an LB plate and incubated in 3 mL LB broth on at 37 °C with 220 rpm for 16 hours. The culture was diluted 1:100 (1 mL in 100 mL) in a 500 mL flask and incubated at 37 °C with 220 rpm until OD<sub>600</sub> reached 0.3 - 0.4. The flask was immediately cooled in an ice-water slurry before the cells were transferred to pre-chilled 50 mL Falcon tubes. Cells were centrifuged at 4000 rpm at 4 °C, supernatant discarded and the cell pellet resuspended in 10 ml ice-cold CaCl<sub>2</sub> solution (60 mM CaCl<sub>2</sub>, 15% glycerol, 10 mM PIPES pH 7). The centrifugation step was repeated, and resuspension was kept on ice for 30 minutes. After another centrifugation step the cells were resuspended in 1 mL ice-cold CaCl<sub>2</sub> solution and aliquots of 50 μL or 100 μL were frozen at -70 °C.</p><p id="P34">For transformation, the chemically competent cells were thawed on ice. 2 μL of plasmid DNA (pEB1-variants; 0.5 ng/mL) was added and incubated on ice for 30 minutes. Cells were heat-shocked for 30 seconds at 42 °C in a water bath and immediately put back on ice for 2 minutes. 900 μL SOC media was added to cells and incubated for 1 hour at 37 °C 220 rpm before being spread on LB kanamycin (50 μg/mL) plates.</p></sec><sec id="S15"><title>Cloning and functional expression of <italic>cat</italic> genes</title><p id="P35">Cat gene variants were amplified using primers spanning the coding sequence with 20 bp overhangs homologous to the pEB1-plasmid cloning site (<xref ref-type="supplementary-material" rid="SD1">supplementary Table S2</xref>). Gibson assembly [<xref ref-type="bibr" rid="R51">51</xref>] (NEBuilder® HiFi DNA Assembly Master Mix, E2621S, NEB, UK) was used to clone <italic>catA1, catA2, catB3</italic> and <italic>catB4</italic> into pEB1. Plasmids were verified by colony PCR and Sanger sequencing of the insert regions using pEB1_sequencing primers (<xref ref-type="supplementary-material" rid="SD1">supplementary Table S2</xref>). Plasmids were extracted using QIAprep Spin Miniprep Kit (27106, Qiagen) and transformed into competent MG1655.</p></sec><sec id="S16"><title>Experimental evolution of CHL resistance</title><p id="P36">Isolates were retrieved from frozen stock on LB agar plates. A single colony was used to inoculate a 1 mL starting culture and incubated at 37 °C with 220 rpm (the ancestor). Then, for each tested isolate the starting culture was diluted 1:100 into 3 tubes with 3 mL LB broth (control populations) and 3 tubes with LB and 0.5x the MIC of CHL (selected populations) of the isolate. All population were incubated for 24 h at 37 °C with 220 rpm and then again diluted 1:100 in fresh LB broth with or without CHL. In the selected population the CHL concentration was doubled with each passage. This was repeated for 7 days or until the population became extinct.</p></sec><sec id="S17"><title>DNA extraction</title><p id="P37">DNA was extracted with MasterPure™ Complete DNA &amp; RNA Purification Kit (MC89010, LGC Biosearch Technologies). Isolates were grown overnight on blood agar (PP0120-9090, E&amp;O labs) at 37°C and colonies were picked and washed in 500 μl of sterile PBS (10010023, Fisher Scientific) by centrifugation at 10,000 x g for 3 minutes. Pellets were resuspended in 300 μl Tissue and Cell Lysis Solution supplemented with 1 μl of Proteinase K solution. Tubes were incubated at 65°C shaking at 1000 rpm for 5 minutes. Samples were placed on ice for 3 minutes. 1 μl of RNase A solution was added and the samples incubated at 37°C for 30 minutes.</p><p id="P38">Samples were placed on ice for 5 minutes then 150 μl of MPC Protein Precipitation Reagent was added and samples vortexed for 10 s. The resulting protein debris was pelleted by centrifugation at 10,000 x g for 10 minutes at 4°C. The supernatant was aspirated and added to 500 μl of isopropanol (15631700, Fisher Scientific) and the tube inverted 30-40 times to precipitate the nucleic acids which were then pelleted by centrifugation at 10,000 x g for 10 minutes at 4°C and supernatant discarded. The pellet was washed twice in 70% ethanol and resuspended in 50 μl of TE Buffer. The quantity of DNA was then measured using Qubit dsDNA Quantitation, Broad Range kit (Q32850, Thermo Scientific) on a Qubit 4 Fluorometer (Thermo Scientific).</p></sec><sec id="S18"><title>Long-read sequencing</title><p id="P39">Five <italic>E. coli</italic> from the subset of 42 isolates with a genotype-phenotype mismatch, were re-streaked from glycerol stocks onto antibiotic supplemented LB Agar and incubated at 37°C for 16 h. A single colony was picked and transferred to LB broth supplemented with antibiotics. Antibiotic supplementation included chloramphenicol and/or ampicillin depending on the resistance profile of each strain. Genomic DNA was extracted using the Firemonkey High Molecular DNA Extraction Kit (Revolugen, UK) according to the manufacturers protocol.</p><p id="P40">The strains were long-read sequenced on a MinION device (Oxford Nanopore Technologies (ONT), UK). Library prep was carried out according to the manufacturer’s protocol (ONT, UK) using the SQK-NBD114.24 Ligation Sequencing and Native Barcoding Kit. The DNA library was quantified at several stages in the library prep using a Qubit Fluorometer (ThermoFisher Scientific, Massachusetts, USA), the TapeStation 4100 (Agilent, California, USA) was used to determine the molar concentration and 10-20 fmol were loaded onto the flow cell. Sequencing was carried out using a FLO-MIN114 (R10.4.1) flow cell (ONT, UK) on a MinION Mk1B sequencer, running for 72 h at a translocation speed of 400bp/s. Data acquisition used the MinKNOW software (v22.08.9).</p></sec><sec id="S19"><title>Bioinformatic analysis</title><p id="P41">The raw fast5 files from the MinION sequencing run were basecalled using Guppy v6.4.2 with the super accuracy (sup) model for DNA sequencing on the R10.4.1 flowcell with the E8.2 motor protein and the 400bp/s translocation speed. Nanoplot v1.38.1 [<xref ref-type="bibr" rid="R52">52</xref>] was used to check the quality of the sequencing reads and the parameters of the sequencing run. The basecalled fastq files were demultiplexed using the guppy_barcoder from Guppy v6.3.8 with the SQK-NBD114-24 kit. The sequence reads were assembled with flye v2.9.1 [<xref ref-type="bibr" rid="R53">53</xref>] using trestle mode. Seqkit v0.15.0 [<xref ref-type="bibr" rid="R54">54</xref>] was used to determine basic statistics and contig sizes (<xref ref-type="supplementary-material" rid="SD1">supplementary Table 3</xref>). The assembled contigs were annotated with RAST [<xref ref-type="bibr" rid="R55">55</xref>] and any query MGEs aligned against the ISfinder database [<xref ref-type="bibr" rid="R56">56</xref>], Mobile Element Finder database [<xref ref-type="bibr" rid="R57">57</xref>] and IntegronFinder [<xref ref-type="bibr" rid="R58">58</xref>]. Resfinder was used to determine resistance genes [<xref ref-type="bibr" rid="R59">59</xref>]. Annotated assemblies were visualised in Snapgene, and clinker [<xref ref-type="bibr" rid="R60">60</xref>] was used on the Genbank files to align the contigs and highlight any homologous genetic clusters.</p></sec><sec id="S20"><title>Co-occurrence analysis of AMR genes</title><p id="P42">Genome sequences (all illumina short read data) for our assembled isolate collection were obtained from the European Nucleotide Archive: PRJEB8265, PRJEB28522, PRJEB26677 and PRJEB36486 [<xref ref-type="bibr" rid="R15">15</xref>–<xref ref-type="bibr" rid="R18">18</xref>]. Fastq files were downloaded in April 2023. Initially, the paired-end short-read fastq files were downloaded and trimmed with cutadapt [<xref ref-type="bibr" rid="R61">61</xref>]. All reads were analysed with FASTQC and found to pass over half the quality control determinants, sequences with a Phred quality score less than Q20 across the length of the reads were excluded. Reads were assembled using SPAdes v3.11.1 [<xref ref-type="bibr" rid="R62">62</xref>]. 68 genomes failed initial QC or assembly and the dataset taken forward for analysis contained 495 <italic>E. coli</italic> and 277 <italic>KpSC</italic> genomes. The quality of the assembled contigs was assessed using the stat command from Seqkit v0.15.0 [<xref ref-type="bibr" rid="R54">54</xref>]. The final dataset contained 772 assembled fasta files.</p><p id="P43">Abricate v0.0.9 (<ext-link ext-link-type="uri" xlink:href="https://github.com/tseemann/abricate">https://github.com/tseemann/abricate</ext-link>) was used to screen for AMR genes and create output tables, sequences were compared against the Resfinder [<xref ref-type="bibr" rid="R59">59</xref>] database at 60% minimum length and 90% percentage identity using the BLASTn algorithm. The R programming language v 4.3.1 was used to convert the abricate output tables into an appropriate format for further data analysis and visualisation, including a binary presence/absence AMR gene table, with the tidyverse (v1.3.0) package [<xref ref-type="bibr" rid="R63">63</xref>]. Any annotation of <italic>catB3</italic> with less than 75% coverage was labelled <italic>catB4</italic>. The cooccur package v1.3 [<xref ref-type="bibr" rid="R64">64</xref>] was used to create a co-occurrence matrix containing the probabilistic values which represent whether a co-occurrence relationship is observed significantly more or less than could have happened by chance. This used the probabilistic model of co-occurrence [<xref ref-type="bibr" rid="R34">34</xref>]. If a pair of genes were observed to co-occur significantly less than expected by chance their relationship was termed negative, if they were observed to co-occur significantly more it was termed positive and any pair of genes which were observed to co-occur with no significant difference from their expected value were termed random. A significant difference was defined as having a p-value ≤ 0.05. Select genes conferring resistance to the phenicol, beta-lactam and aminoglycoside drug classes were then selected from the original presence/absence table for further analysis. Heatmaps to display co-occurrence were visualised using ggplot v 3.4.3 [<xref ref-type="bibr" rid="R63">63</xref>] and pheatmap v 1.0.12. Clustering in the heatmap used hierarchical clustering with Euclidian distance and the complete method.</p></sec><sec id="S21"><title>ST analysis</title><p id="P44">The genome assemblies of 100 randomly selected isolates from each of the 100 most common STs in Enterobase were downloaded on 18/12/2020. Extra genomes from ST391, ST44, ST940 and ST9847 with release date before 18/12/2020 were added later to match with the STs from the Malawi dataset. The STs of the Malawi dataset were determined using MLST (v2.23.0). The presence of <italic>cat</italic> genes was detected using AMRFinderPlus version 3.11.20 with database version 2023-09-26.1 [<xref ref-type="bibr" rid="R65">65</xref>]. The data was analysed using R (v4.1.3) with the tidyverse package (v1.3.1) and plotted using ggplot2 (v3.4.2), ggpubr (v0.4.0), and RColorBrewer (v1.1-2).</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary materials</label><media xlink:href="EMS191297-supplement-Supplementary_materials.pdf" mimetype="application" mime-subtype="pdf" id="d7aAdEbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S22"><title>Acknowledgements</title><p>We wish to thank Dr Anne Farewell for <italic>E. coli</italic> MG1655. pEB1-sfGFP was a kind gift from Philippe Cluzel (Addgene: <ext-link ext-link-type="uri" xlink:href="http://n2t.net/addgene:103983">http://n2t.net/addgene:103983</ext-link>). We also wish to thank Dr Simon Wagstaff for the GPU base-calling of Oxford Nanopore data and Dr Nadja Wipf for critically reviewing R-code.</p><sec id="S23"><title>Funding</title><p>This work was supported by iiCON (infection innovation consortium) via UK Research and Innovation (107136) and Unilever (MA-2021-00523N). R.N.G. has been supported by the Medical Research Council via the LSTM-Lancaster doctoral training partnership (grant no. MR/N013514/1). R.N.G and A.P.R. are supported by the Medical Research Council (MRC), Biotechnology and Biological Sciences Research Council (BBSRC) and Natural Environmental Research Council (NERC) which are all Councils of UK Research and Innovation (Grant no. MR/W030578/1) under the umbrella of the JPIAMR - Joint Programming Initiative on Antimicrobial Resistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></sec></ack><sec id="S24" sec-type="data-availability"><title>Supplementary materials and data availability</title><p id="P45"><xref ref-type="supplementary-material" rid="SD1">Supplementary Figures 1-8</xref> and <xref ref-type="supplementary-material" rid="SD1">supplementary Tables 2 &amp; 3</xref> are accessible in the supplementary material of this manuscript. Reads from all isolates previously sequenced and used in this study are accessible in the European Nucleotide Archive (ENA) under project IDs PRJEB8265, PRJEB26677, PRJEB28522 and PRJEB36486 and ENA accession numbers for isolates linked to metadata are available in the <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>. Long-read sequence data have been submitted to the National Center for Biotechnology Information (NCBI) under the BioProject ID PRJNA1040831, BioSample accession numbers for sequenced isolates are in <xref ref-type="supplementary-material" rid="SD1">supplementary Table 3</xref>. The R scripts used to generate analyses, figures and tables, and <xref ref-type="supplementary-material" rid="SD1">supplementary Tables 1 &amp; 4</xref> are available from the GitHub repository <ext-link ext-link-type="uri" xlink:href="https://github.com/FEGraf/CHL-Malawi">https://github.com/FEGraf/CHL-Malawi</ext-link>.</p></sec><fn-group><fn id="FN1" fn-type="con"><p id="P46"><bold>Author contributions</bold></p><p id="P47">The study was conceived by F.E.G., A.P.R., and N.A.F. The methodology was devised by F.E.G., R.N.G., MD.P., M.A.S., A.P.R., T.E., J.M.L. and N.A.F. Investigations were undertaken by F.E.G., R.N.G., S.G., S.F., E.PB., A.J.F., MD.P., M.M., A.T.M .H., P.M., T.E., and J.M.L. Formal analysis was done F.E.G., R.N.G., MD.P., P.M., M.A.S., A.P.R., T.E., J.M.L. and N.A.F. The original draft was prepared by F.E.G., R.N.G, J.M.L. and N.A.F., and then reviewed and edited by all authors. Supervision was by F.E.G., T.E., A.P.R. and N.A.F.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><collab>Antimicrobial Resistance, C</collab><article-title>Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis</article-title><source>Lancet</source><year>2022</year><volume>399</volume><issue>10325</issue><fpage>629</fpage><lpage>655</lpage><pub-id pub-id-type="pmcid">PMC8841637</pub-id><pub-id pub-id-type="pmid">35065702</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(21)02724-0</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tacconelli</surname><given-names>E</given-names></name><etal/></person-group><article-title>Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis</article-title><source>Lancet Infect Dis</source><year>2018</year><volume>18</volume><issue>3</issue><fpage>318</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">29276051</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lester</surname><given-names>R</given-names></name><etal/></person-group><article-title>Effect of resistance to third-generation cephalosporins on morbidity and mortality from bloodstream infections in Blantyre, Malawi: a prospective cohort study</article-title><source>Lancet Microbe</source><year>2022</year><volume>3</volume><issue>12</issue><fpage>e922</fpage><lpage>e930</lpage><pub-id pub-id-type="pmcid">PMC9712123</pub-id><pub-id pub-id-type="pmid">36335953</pub-id><pub-id pub-id-type="doi">10.1016/S2666-5247(22)00282-8</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lester</surname><given-names>R</given-names></name><etal/></person-group><article-title>Individual and population level costs and health-related quality of life outcomes of third-generation cephalosporin resistant bloodstream infection in Blantyre, Malawi</article-title><source>PLOS Glob Public Health</source><year>2023</year><volume>3</volume><issue>6</issue><elocation-id>e0001589</elocation-id><pub-id pub-id-type="pmcid">PMC10287011</pub-id><pub-id pub-id-type="pmid">37347746</pub-id><pub-id pub-id-type="doi">10.1371/journal.pgph.0001589</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musicha</surname><given-names>P</given-names></name><etal/></person-group><article-title>Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998–2016): a surveillance study</article-title><source>The Lancet Infectious Diseases</source><year>2017</year><volume>17</volume><issue>10</issue><fpage>1042</fpage><lpage>1052</lpage><pub-id pub-id-type="pmcid">PMC5610140</pub-id><pub-id pub-id-type="pmid">28818544</pub-id><pub-id pub-id-type="doi">10.1016/S1473-3099(17)30394-8</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="book"><collab>Ministry of Health, G.o.M</collab><source>Malawi Standard Treatmemt Guidelines (MSTG)</source><year>2015</year><edition>5th edn</edition></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrlich</surname><given-names>J</given-names></name><etal/></person-group><article-title>Chloromycetin, a New Antibiotic From a Soil Actinomycete</article-title><source>Science</source><year>1947</year><volume>106</volume><issue>2757</issue><fpage>417</fpage><pub-id pub-id-type="pmid">17737966</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eliakim-Raz</surname><given-names>N</given-names></name><etal/></person-group><article-title>Efficacy and safety of chloramphenicol: joining the revival of old antibiotics? Systematic review and meta-analysis of randomized controlled trials</article-title><source>J Antimicrob Chemother</source><year>2015</year><volume>70</volume><issue>4</issue><fpage>979</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">25583746</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rheingold</surname><given-names>JJ</given-names></name><name><surname>Spurling</surname><given-names>CL</given-names></name></person-group><article-title>Chloramphenicol and aplastic anemia</article-title><source>J Am Med Assoc</source><year>1952</year><volume>119</volume><issue>14</issue><fpage>1301</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">14938166</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schilling</surname><given-names>CG</given-names></name><name><surname>Larson</surname><given-names>TA</given-names></name><name><surname>Uden</surname><given-names>DL</given-names></name></person-group><article-title>Chloramphenicol-Associated Aplastic Anemia</article-title><source>Journal of Pharmacy Technology</source><year>1988</year><volume>4</volume><issue>2</issue><fpage>54</fpage><lpage>59</lpage></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martelo</surname><given-names>OJ</given-names></name><etal/></person-group><article-title>Chloramphenicol and bone marrow mitochondria</article-title><source>J Lab Clin Med</source><year>1969</year><volume>74</volume><issue>6</issue><fpage>927</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">5359665</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIntyre</surname><given-names>J</given-names></name><name><surname>Choonara</surname><given-names>I</given-names></name></person-group><article-title>Drug toxicity in the neonate</article-title><source>Biol Neonate</source><year>2004</year><volume>86</volume><issue>4</issue><fpage>218</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">15249753</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>S</given-names></name><etal/></person-group><article-title>Molecular basis of bacterial resistance to chloramphenicol and florfenicol</article-title><source>FEMS Microbiol Rev</source><year>2004</year><volume>28</volume><issue>5</issue><fpage>519</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">15539072</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Colonization dynamics of extended-spectrum beta-lactamase-producing Enterobacterales in the gut of Malawian adults</article-title><source>Nat Microbiol</source><year>2022</year><volume>7</volume><issue>10</issue><fpage>1593</fpage><lpage>1604</lpage><pub-id pub-id-type="pmcid">PMC9519460</pub-id><pub-id pub-id-type="pmid">36065064</pub-id><pub-id pub-id-type="doi">10.1038/s41564-022-01216-7</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musicha</surname><given-names>P</given-names></name><etal/></person-group><article-title>Genomic landscape of extended-spectrum beta-lactamase resistance in Escherichia coli from an urban African setting</article-title><source>J Antimicrob Chemother</source><year>2017</year><volume>72</volume><issue>6</issue><fpage>1602</fpage><lpage>1609</lpage><pub-id pub-id-type="pmcid">PMC5437524</pub-id><pub-id pub-id-type="pmid">28333330</pub-id><pub-id pub-id-type="doi">10.1093/jac/dkx058</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musicha</surname><given-names>P</given-names></name><etal/></person-group><article-title>Genomic analysis of Klebsiella pneumoniae isolates from Malawi reveals acquisition of multiple ESBL determinants across diverse lineages</article-title><source>J Antimicrob Chemother</source><year>2019</year><volume>74</volume><issue>5</issue><fpage>1223</fpage><lpage>1232</lpage><pub-id pub-id-type="pmcid">PMC6477993</pub-id><pub-id pub-id-type="pmid">30778540</pub-id><pub-id pub-id-type="doi">10.1093/jac/dkz032</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Genomic and antigenic diversity of colonizing Klebsiella pneumoniae isolates mirrors that of invasive isolates in Blantyre, Malawi</article-title><source>Microb Genom</source><year>2022</year><volume>8</volume><issue>3</issue><pub-id pub-id-type="pmcid">PMC9176273</pub-id><pub-id pub-id-type="pmid">35302438</pub-id><pub-id pub-id-type="doi">10.1099/mgen.0.000778</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Genomic analysis of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli colonising adults in Blantyre, Malawi reveals previously undescribed diversity</article-title><source>Microb Genom</source><year>2023</year><volume>9</volume><issue>6</issue><pub-id pub-id-type="pmcid">PMC10327512</pub-id><pub-id pub-id-type="pmid">37314322</pub-id><pub-id pub-id-type="doi">10.1099/mgen.0.001035</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azemun</surname><given-names>P</given-names></name><etal/></person-group><article-title>Rapid detection of chloramphenicol resistance in Haemophilus influenzae</article-title><source>Antimicrob Agents Chemother</source><year>1981</year><volume>20</volume><issue>2</issue><fpage>168</fpage><lpage>70</lpage><pub-id pub-id-type="pmcid">PMC181658</pub-id><pub-id pub-id-type="pmid">6974540</pub-id><pub-id pub-id-type="doi">10.1128/aac.20.2.168</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slack</surname><given-names>MP</given-names></name><name><surname>Wheldon</surname><given-names>DB</given-names></name><name><surname>Turk</surname><given-names>DC</given-names></name></person-group><article-title>Rapid detection of chloramphenicol resistance in Haemophilus influenzae</article-title><source>Lancet</source><year>1977</year><volume>2</volume><issue>8052-8053</issue><elocation-id>1366</elocation-id><pub-id pub-id-type="pmid">74780</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Projan</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Comparative sequence and functional analysis of pT181 and pC221, cognate plasmid replicons from Staphylococcus aureus</article-title><source>Mol Gen Genet</source><year>1985</year><volume>199</volume><issue>3</issue><fpage>452</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">2993795</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovett</surname><given-names>PS</given-names></name></person-group><article-title>Translational attenuation as the regulator of inducible cat genes</article-title><source>J Bacteriol</source><year>1990</year><volume>172</volume><issue>1</issue><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmcid">PMC208393</pub-id><pub-id pub-id-type="pmid">2403536</pub-id><pub-id pub-id-type="doi">10.1128/jb.172.1.1-6.1990</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balleza</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>JM</given-names></name><name><surname>Cluzel</surname><given-names>P</given-names></name></person-group><article-title>Systematic characterization of maturation time of fluorescent proteins in living cells</article-title><source>Nat Methods</source><year>2018</year><volume>15</volume><issue>1</issue><fpage>47</fpage><lpage>51</lpage><pub-id pub-id-type="pmcid">PMC5765880</pub-id><pub-id pub-id-type="pmid">29320486</pub-id><pub-id pub-id-type="doi">10.1038/nmeth.4509</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>JM</given-names></name></person-group><article-title>Causes and consequences of adult sepsis in Blantyre, Malawi</article-title><year>2019</year></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Partridge</surname><given-names>SR</given-names></name><name><surname>Zong</surname><given-names>Z</given-names></name><name><surname>Iredell</surname><given-names>JR</given-names></name></person-group><article-title>Recombination in IS26 and Tn2 in the evolution of multiresistance regions carrying blaCTX-M-15 on conjugative IncF plasmids from Escherichia coli</article-title><source>Antimicrob Agents Chemother</source><year>2011</year><volume>55</volume><issue>11</issue><fpage>4971</fpage><lpage>8</lpage><pub-id pub-id-type="pmcid">PMC3195058</pub-id><pub-id pub-id-type="pmid">21859935</pub-id><pub-id pub-id-type="doi">10.1128/AAC.00025-11</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pong</surname><given-names>CH</given-names></name><name><surname>Moran</surname><given-names>RA</given-names></name><name><surname>Hall</surname><given-names>RM</given-names></name></person-group><article-title>Evolution of IS26-bounded pseudo-compound transposons carrying the tet(C) tetracycline resistance determinant</article-title><source>Plasmid</source><year>2020</year><volume>112</volume><elocation-id>102541</elocation-id><pub-id pub-id-type="pmid">32979461</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodford</surname><given-names>N</given-names></name><etal/></person-group><article-title>Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone</article-title><source>Antimicrob Agents Chemother</source><year>2009</year><volume>53</volume><issue>10</issue><fpage>4472</fpage><lpage>82</lpage><pub-id pub-id-type="pmcid">PMC2764225</pub-id><pub-id pub-id-type="pmid">19687243</pub-id><pub-id pub-id-type="doi">10.1128/AAC.00688-09</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inouye</surname><given-names>M</given-names></name><etal/></person-group><article-title>SRST2: Rapid genomic surveillance for public health and hospital microbiology labs</article-title><source>Genome Med</source><year>2014</year><volume>6</volume><issue>11</issue><fpage>90</fpage><pub-id pub-id-type="pmcid">PMC4237778</pub-id><pub-id pub-id-type="pmid">25422674</pub-id><pub-id pub-id-type="doi">10.1186/s13073-014-0090-6</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McArthur</surname><given-names>AG</given-names></name><etal/></person-group><article-title>The comprehensive antibiotic resistance database</article-title><source>Antimicrob Agents Chemother</source><year>2013</year><volume>57</volume><issue>7</issue><fpage>3348</fpage><lpage>57</lpage><pub-id pub-id-type="pmcid">PMC3697360</pub-id><pub-id pub-id-type="pmid">23650175</pub-id><pub-id pub-id-type="doi">10.1128/AAC.00419-13</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Florensa</surname><given-names>AF</given-names></name><etal/></person-group><article-title>ResFinder - an open online resource for identification of antimicrobial resistance genes in next-generation sequencing data and prediction of phenotypes from genotypes</article-title><source>Microb Genom</source><year>2022</year><volume>8</volume><issue>1</issue><pub-id pub-id-type="pmcid">PMC8914360</pub-id><pub-id pub-id-type="pmid">35072601</pub-id><pub-id pub-id-type="doi">10.1099/mgen.0.000748</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quiroga</surname><given-names>MP</given-names></name><etal/></person-group><article-title>Complex class 1 integrons with diverse variable regions, including aac(6)-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina</article-title><source>Antimicrob Agents Chemother</source><year>2007</year><volume>51</volume><issue>12</issue><fpage>4466</fpage><lpage>70</lpage><pub-id pub-id-type="pmcid">PMC2167984</pub-id><pub-id pub-id-type="pmid">17938184</pub-id><pub-id pub-id-type="doi">10.1128/AAC.00726-07</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>TK</given-names></name><name><surname>Browne</surname><given-names>PD</given-names></name><name><surname>Hansen</surname><given-names>LH</given-names></name></person-group><article-title>Antibiotic resistance genes are differentially mobilized according to resistance mechanism</article-title><source>Gigascience</source><year>2022</year><volume>11</volume><pub-id pub-id-type="pmcid">PMC9338424</pub-id><pub-id pub-id-type="pmid">35906888</pub-id><pub-id pub-id-type="doi">10.1093/gigascience/giac072</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>CT</given-names></name><etal/></person-group><article-title>ChloS-HRM, a novel assay to identify chloramphenicol-susceptible Escherichia coli and Klebsiella pneumoniae in Malawi</article-title><source>J Antimicrob Chemother</source><year>2019</year><volume>74</volume><issue>5</issue><fpage>1212</fpage><lpage>1217</lpage><pub-id pub-id-type="pmcid">PMC6477986</pub-id><pub-id pub-id-type="pmid">30689880</pub-id><pub-id pub-id-type="doi">10.1093/jac/dky563</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veech</surname><given-names>JA</given-names></name><name><surname>Peres-Neto</surname><given-names>P</given-names></name></person-group><article-title>A probabilistic model for analysing species co occurrence</article-title><source>Global Ecology and Biogeography</source><year>2013</year><volume>22</volume><issue>2</issue><fpage>252</fpage><lpage>260</lpage></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldgarden</surname><given-names>M</given-names></name><etal/></person-group><article-title>Curation of the AMRFinderPlus databases: applications, functionality and impact</article-title><source>Microb Genom</source><year>2022</year><volume>8</volume><issue>6</issue><pub-id pub-id-type="pmcid">PMC9455714</pub-id><pub-id pub-id-type="pmid">35675101</pub-id><pub-id pub-id-type="doi">10.1099/mgen.0.000832</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phan</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Plasmid-Mediated Ciprofloxacin Resistance Imparts a Selective Advantage on Escherichia coli ST131</article-title><source>Antimicrob Agents Chemother</source><year>2022</year><volume>66</volume><issue>1</issue><elocation-id>e0214621</elocation-id><pub-id pub-id-type="pmcid">PMC8765324</pub-id><pub-id pub-id-type="pmid">34780264</pub-id><pub-id pub-id-type="doi">10.1128/AAC.02146-21</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petty</surname><given-names>NK</given-names></name><etal/></person-group><article-title>Global dissemination of a multidrug resistant Escherichia coli clone</article-title><source>Proc Natl Acad Sci U S A</source><year>2014</year><volume>111</volume><issue>15</issue><fpage>5694</fpage><lpage>9</lpage><pub-id pub-id-type="pmcid">PMC3992628</pub-id><pub-id pub-id-type="pmid">24706808</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1322678111</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>JR</given-names></name><etal/></person-group><article-title>Rapid Emergence, Subsidence, and Molecular Detection of Escherichia coli Sequence Type 1193-fimH64, a New Disseminated Multidrug Resistant Commensal and Extraintestinal Pathogen</article-title><source>J Clin Microbiol</source><year>2019</year><volume>57</volume><issue>5</issue><pub-id pub-id-type="pmcid">PMC6498021</pub-id><pub-id pub-id-type="pmid">30787145</pub-id><pub-id pub-id-type="doi">10.1128/JCM.01664-18</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potrykus</surname><given-names>J</given-names></name><name><surname>Wegrzyn</surname><given-names>G</given-names></name></person-group><article-title>Chloramphenicol-sensitive Escherichia coli strain expressing the chloramphenicol acetyltransferase (cat) gene</article-title><source>Antimicrob Agents Chemother</source><year>2001</year><volume>45</volume><issue>12</issue><fpage>3610</fpage><lpage>2</lpage><pub-id pub-id-type="pmcid">PMC90880</pub-id><pub-id pub-id-type="pmid">11709351</pub-id><pub-id pub-id-type="doi">10.1128/AAC.45.12.3610-3612.2001</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potrykus</surname><given-names>J</given-names></name><name><surname>Wegrzyn</surname><given-names>G</given-names></name></person-group><article-title>The acrAB locus is involved in modulating intracellular acetyl coenzyme A levels in a strain of Escherichia coli CM2555 expressing the chloramphenicol acetyltransferase (cat) gene</article-title><source>Arch Microbiol</source><year>2003</year><volume>180</volume><issue>5</issue><fpage>362</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">14614545</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pulford</surname><given-names>CV</given-names></name><etal/></person-group><article-title>Stepwise evolution of Salmonella Typhimurium ST313 causing bloodstream infection in Africa</article-title><source>Nat Microbiol</source><year>2021</year><volume>6</volume><issue>3</issue><fpage>327</fpage><lpage>338</lpage><pub-id pub-id-type="pmcid">PMC8018540</pub-id><pub-id pub-id-type="pmid">33349664</pub-id><pub-id pub-id-type="doi">10.1038/s41564-020-00836-1</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Civljak</surname><given-names>R</given-names></name><etal/></person-group><article-title>Could chloramphenicol be used against ESKAPE pathogens? A review of in vitro data in the literature from the 21st century</article-title><source>Expert Rev Anti Infect Ther</source><year>2014</year><volume>12</volume><issue>2</issue><fpage>249</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">24392752</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sood</surname><given-names>S</given-names></name></person-group><article-title>Chloramphenicol - A Potent Armament Against Multi-Drug Resistant (MDR) Gram Negative Bacilli?</article-title><source>J Clin Diagn Res</source><year>2016</year><volume>10</volume><issue>2</issue><fpage>DC01</fpage><lpage>3</lpage><pub-id pub-id-type="pmcid">PMC4800523</pub-id><pub-id pub-id-type="pmid">27042458</pub-id><pub-id pub-id-type="doi">10.7860/JCDR/2016/14989.7167</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohana</surname><given-names>H</given-names></name><etal/></person-group><article-title>Trend of Changes in Chloramphenicol Resistance during the Years 2017-2020: A Retrospective Report from Israel</article-title><source>Antibiotics (Basel)</source><year>2023</year><volume>12</volume><issue>2</issue><pub-id pub-id-type="pmcid">PMC9952794</pub-id><pub-id pub-id-type="pmid">36830107</pub-id><pub-id pub-id-type="doi">10.3390/antibiotics12020196</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glazko</surname><given-names>AJ</given-names></name><name><surname>Wolf</surname><given-names>LM</given-names></name><etal/></person-group><article-title>Biochemical studies on chloramphenicol; tissue distribution and excretion studies</article-title><source>J Pharmacol Exp Ther</source><year>1949</year><volume>96</volume><issue>4 Pt. 1</issue><fpage>445</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">18137900</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambrose</surname><given-names>PJ</given-names></name></person-group><article-title>Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate</article-title><source>Clin Pharmacokinet</source><year>1984</year><volume>9</volume><issue>3</issue><fpage>222</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">6375931</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geurtsen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Genomics and pathotypes of the many faces of Escherichia coli</article-title><source>FEMS Microbiol Rev</source><year>2022</year><volume>46</volume><issue>6</issue><pub-id pub-id-type="pmcid">PMC9629502</pub-id><pub-id pub-id-type="pmid">35749579</pub-id><pub-id pub-id-type="doi">10.1093/femsre/fuac031</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harmer</surname><given-names>CJ</given-names></name><name><surname>Moran</surname><given-names>RA</given-names></name><name><surname>Hall</surname><given-names>RM</given-names></name></person-group><article-title>Movement of IS26-associated antibiotic resistance genes occurs via a translocatable unit that includes a single IS26 and preferentially inserts adjacent to another IS26</article-title><source>mBio</source><year>2014</year><volume>5</volume><issue>5</issue><elocation-id>e01801-14</elocation-id><pub-id pub-id-type="pmcid">PMC4196232</pub-id><pub-id pub-id-type="pmid">25293759</pub-id><pub-id pub-id-type="doi">10.1128/mBio.01801-14</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harmer</surname><given-names>CJ</given-names></name><name><surname>Hall</surname><given-names>RM</given-names></name></person-group><article-title>IS26 cannot move alone</article-title><source>J Antimicrob Chemother</source><year>2021</year><volume>76</volume><issue>6</issue><fpage>1428</fpage><lpage>1432</lpage><pub-id pub-id-type="pmid">33686401</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>JL</given-names></name><name><surname>Coque</surname><given-names>TM</given-names></name><name><surname>Baquero</surname><given-names>F</given-names></name></person-group><article-title>What is a resistance gene? Ranking risk in resistomes</article-title><source>Nat Rev Microbiol</source><year>2015</year><volume>13</volume><issue>2</issue><fpage>116</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">25534811</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>DG</given-names></name><etal/></person-group><article-title>Enzymatic assembly of DNA molecules up to several hundred kilobases</article-title><source>Nat Methods</source><year>2009</year><volume>6</volume><issue>5</issue><fpage>343</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">19363495</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Coster</surname><given-names>W</given-names></name><etal/></person-group><article-title>NanoPack: visualizing and processing long-read sequencing data</article-title><source>Bioinformatics</source><year>2018</year><volume>34</volume><issue>15</issue><fpage>2666</fpage><lpage>2669</lpage><pub-id pub-id-type="pmcid">PMC6061794</pub-id><pub-id pub-id-type="pmid">29547981</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/bty149</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolmogorov</surname><given-names>M</given-names></name><etal/></person-group><article-title>Assembly of long, error-prone reads using repeat graphs</article-title><source>Nat Biotechnol</source><year>2019</year><volume>37</volume><issue>5</issue><fpage>540</fpage><lpage>546</lpage><pub-id pub-id-type="pmid">30936562</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>W</given-names></name><etal/></person-group><article-title>SeqKit: A Cross-Platform and Ultrafast Toolkit for FASTA/Q File Manipulation</article-title><source>PLoS One</source><year>2016</year><volume>11</volume><issue>10</issue><elocation-id>e0163962</elocation-id><pub-id pub-id-type="pmcid">PMC5051824</pub-id><pub-id pub-id-type="pmid">27706213</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0163962</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aziz</surname><given-names>RK</given-names></name><etal/></person-group><article-title>The RAST Server: rapid annotations using subsystems technology</article-title><source>BMC Genomics</source><year>2008</year><volume>9</volume><fpage>75</fpage><pub-id pub-id-type="pmcid">PMC2265698</pub-id><pub-id pub-id-type="pmid">18261238</pub-id><pub-id pub-id-type="doi">10.1186/1471-2164-9-75</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siguier</surname><given-names>P</given-names></name><etal/></person-group><article-title>ISfinder: the reference centre for bacterial insertion sequences</article-title><source>Nucleic Acids Res</source><year>2006</year><volume>34</volume><fpage>D32</fpage><lpage>6</lpage><pub-id pub-id-type="pmcid">PMC1347377</pub-id><pub-id pub-id-type="pmid">16381877</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkj014</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>MHK</given-names></name><etal/></person-group><article-title>Detection of mobile genetic elements associated with antibiotic resistance in Salmonella enterica using a newly developed web tool: MobileElementFinder</article-title><source>J Antimicrob Chemother</source><year>2021</year><volume>76</volume><issue>1</issue><fpage>101</fpage><lpage>109</lpage><pub-id pub-id-type="pmcid">PMC7729385</pub-id><pub-id pub-id-type="pmid">33009809</pub-id><pub-id pub-id-type="doi">10.1093/jac/dkaa390</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neron</surname><given-names>B</given-names></name><etal/></person-group><article-title>IntegronFinder 2.0: Identification and Analysis of Integrons across Bacteria, with a Focus on Antibiotic Resistance in Klebsiella</article-title><source>Microorganisms</source><year>2022</year><volume>10</volume><issue>4</issue><pub-id pub-id-type="pmcid">PMC9024848</pub-id><pub-id pub-id-type="pmid">35456751</pub-id><pub-id pub-id-type="doi">10.3390/microorganisms10040700</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bortolaia</surname><given-names>V</given-names></name><etal/></person-group><article-title>ResFinder 4.0 for predictions of phenotypes from genotypes</article-title><source>J Antimicrob Chemother</source><year>2020</year><volume>75</volume><issue>12</issue><fpage>3491</fpage><lpage>3500</lpage><pub-id pub-id-type="pmcid">PMC7662176</pub-id><pub-id pub-id-type="pmid">32780112</pub-id><pub-id pub-id-type="doi">10.1093/jac/dkaa345</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilchrist</surname><given-names>CLM</given-names></name><name><surname>Chooi</surname><given-names>YH</given-names></name></person-group><article-title>clinker &amp; clustermap.js: automatic generation of gene cluster comparison figures</article-title><source>Bioinformatics</source><year>2021</year><volume>37</volume><issue>16</issue><fpage>2473</fpage><lpage>2475</lpage><pub-id pub-id-type="pmid">33459763</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>M</given-names></name></person-group><article-title>Cutadapt removes adapter sequences from high-throughput sequencing reads</article-title><year>2011</year><volume>17</volume><issue>1</issue><fpage>3</fpage><comment>2011</comment></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bankevich</surname><given-names>A</given-names></name><etal/></person-group><article-title>SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing</article-title><source>J Comput Biol</source><year>2012</year><volume>19</volume><issue>5</issue><fpage>455</fpage><lpage>77</lpage><pub-id pub-id-type="pmcid">PMC3342519</pub-id><pub-id pub-id-type="pmid">22506599</pub-id><pub-id pub-id-type="doi">10.1089/cmb.2012.0021</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H</given-names></name><etal/></person-group><article-title>Welcome to the Tidyverse</article-title><source>Journal of Open Source Software</source><year>2019</year><volume>4</volume><issue>43</issue></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffith</surname><given-names>DM</given-names></name><name><surname>Veech</surname><given-names>JA</given-names></name><name><surname>Marsh</surname><given-names>CJ</given-names></name></person-group><article-title>cooccur: Probabilistic Species Co occurrence Analysis inR</article-title><source>Journal of Statistical Software</source><year>2016</year><volume>69</volume><issue>Code Snippet 2</issue></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldgarden</surname><given-names>M</given-names></name><etal/></person-group><article-title>AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence</article-title><source>Sci Rep</source><year>2021</year><volume>11</volume><issue>1</issue><elocation-id>12728</elocation-id><pub-id pub-id-type="pmcid">PMC8208984</pub-id><pub-id pub-id-type="pmid">34135355</pub-id><pub-id pub-id-type="doi">10.1038/s41598-021-91456-0</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig. 1</label><caption><title>Characteristics of isolates.</title><p><bold>a</bold> Chloramphenicol susceptibility of <italic>E. coli</italic> and <italic>KpSC</italic> isolates. <bold>b</bold> Number of CHL susceptible isolates carrying <italic>cat</italic> genes, <italic>floR</italic> or <italic>cmlA</italic> genes, both <italic>(cat</italic> + <italic>floR</italic> or <italic>cmlA</italic>) or no CHL resistance genes. <bold>c</bold> Number of CHL resistance genes present in the 840 Malawian isolates.</p></caption><graphic xlink:href="EMS191297-f001"/></fig><fig id="F2" position="float"><label>Fig. 2</label><caption><title>CAT enzyme activity.</title><p>CAT enzyme activity was measured using the rapid CAT assay. The difference ((signal + CHL) - (signal - CHL) for a single isolate (n = 2-6)) in absorbance at 405 nm is given for each of the 42 isolates. Colour indicates if the isolate is phenotypically resistant (R, blue) or susceptible (S, yellow) to chloramphenicol based on microbroth dilution and the shape indicates <italic>E. coli</italic> (circle) or <italic>K. pneumoniae</italic> (triangle). The Y axis is ordered according to presence of <italic>cat</italic> genes.</p></caption><graphic xlink:href="EMS191297-f002"/></fig><fig id="F3" position="float"><label>Fig. 3</label><caption><title><italic>Cat</italic> gene degradation by insertion sequences.</title><p><bold>a</bold> Schematic of IS<italic>26</italic> truncation of <italic>catB3.</italic> <bold>b</bold> Alignment of four contigs from four different isolates containing either <italic>catB3</italic> and <italic>catB3Δ<sup>443-633</sup>.</italic> <bold>c</bold> Alignment of two genomes containing <italic>catA1</italic>, with and without an IS<italic>5</italic> insertion into the <italic>catA1</italic> promoter.</p></caption><graphic xlink:href="EMS191297-f003"/></fig><fig id="F4" position="float"><label>Fig. 4</label><caption><title>Co-occurrence networks of AMR genes.</title><p>Heatmap displaying co-occurrence relationships between AMR genes as either positive (blue), random (grey) or negative (orange). These are probabilistic values based on the difference in expected and observed frequencies of co-occurrence between each pair of genes, these values were obtained by applying the probabilistic model from [<xref ref-type="bibr" rid="R34">34</xref>]. Co-occurrence across select genes including <italic>cat genes, aac(6’)-Ib-cr, <italic>bla</italic><sub>oxA-1</sub></italic>, bla<sub><italic>CTX-M-15</italic></sub> and <italic>bla<sub>TEM-1</sub></italic>.</p></caption><graphic xlink:href="EMS191297-f004"/></fig><fig id="F5" position="float"><label>Fig. 5</label><caption><p><bold>Cat genes occurrence and proportions per Sequence type</bold> in <italic>E. coli</italic> isolates from Malawi included in our study (top panel) and in a 10k genome collection of 100 randomly selected genomes of the top 100 most common STs from <italic>E. coli</italic>.</p></caption><graphic xlink:href="EMS191297-f005"/></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Isolates functionally characterised in this study.</title></caption><table frame="hsides" rules="groups"><thead><tr style="background-color:#CECBCE"><th align="center" valign="middle">ID</th><th align="center" valign="middle">ST</th><th align="center" valign="middle">Species</th><th align="center" valign="middle">CHL MIC</th><th align="center" valign="middle">R/S</th><th align="center" valign="middle">CHL R gene(s) present</th></tr></thead><tbody><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAE137</td><td align="center" valign="middle">648</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">512</td><td align="center" valign="middle">R</td><td align="center" valign="middle"><italic>catA1, catB4</italic></td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAD110</td><td align="center" valign="middle">424</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">512</td><td align="center" valign="middle">R</td><td align="center" valign="middle"><italic>catA2, catB4, cmlA5</italic></td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAB199</td><td align="center" valign="middle">44</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">128</td><td align="center" valign="middle">R</td><td align="center" valign="middle"><italic>catB4, floR</italic></td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAC122</td><td align="center" valign="middle">101</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">32</td><td align="center" valign="middle">R</td><td align="center" valign="middle"><italic>cat_pC221, cmlA1</italic></td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAC10A</td><td align="center" valign="middle">167</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">16</td><td align="center" valign="middle">R</td><td align="center" valign="middle"><italic>catA1</italic></td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAG10A</td><td align="center" valign="middle">46</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">16</td><td align="center" valign="middle">R</td><td align="center" valign="middle"><italic>catB3</italic></td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAI104</td><td align="center" valign="middle">46</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">16</td><td align="center" valign="middle">R</td><td align="center" valign="middle"><italic>catB3</italic></td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAD10B</td><td align="center" valign="middle">46</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">16</td><td align="center" valign="middle">R</td><td align="center" valign="middle"><italic>catB3</italic></td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAD105</td><td align="center" valign="middle">46</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">16</td><td align="center" valign="middle">R</td><td align="center" valign="middle"><italic>catB3</italic></td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAC10H</td><td align="center" valign="middle">617</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">16</td><td align="center" valign="middle">R</td><td align="center" valign="middle"><italic>catB4</italic></td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAN108</td><td align="center" valign="middle">617</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">16</td><td align="center" valign="middle">R</td><td align="center" valign="middle">none</td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAB17W</td><td align="center" valign="middle">131</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">16</td><td align="center" valign="middle">R</td><td align="center" valign="middle">none</td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAE11U</td><td align="center" valign="middle">167</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">12</td><td align="center" valign="middle">R</td><td align="center" valign="middle">none</td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAB184</td><td align="center" valign="middle">44</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">8</td><td align="center" valign="middle">S</td><td align="center" valign="middle"><italic>catA1, catB4</italic></td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAI10X</td><td align="center" valign="middle">167</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">8</td><td align="center" valign="middle">S</td><td align="center" valign="middle"><italic>catA1</italic></td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAI10E</td><td align="center" valign="middle">167</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">8</td><td align="center" valign="middle">S</td><td align="center" valign="middle"><italic>catA1</italic></td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAC124</td><td align="center" valign="middle">131</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">8</td><td align="center" valign="middle">S</td><td align="center" valign="middle"><italic>catB4</italic></td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAD13N</td><td align="center" valign="middle">410</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">8</td><td align="center" valign="middle">S</td><td align="center" valign="middle"><italic>catB4</italic></td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAE12L</td><td align="center" valign="middle">44</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">8</td><td align="center" valign="middle">S</td><td align="center" valign="middle"><italic>catB4</italic></td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAD13L</td><td align="center" valign="middle">410</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">8</td><td align="center" valign="middle">S</td><td align="center" valign="middle"><italic>catB4</italic></td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAC116</td><td align="center" valign="middle">167</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">8</td><td align="center" valign="middle">S</td><td align="center" valign="middle">none</td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAC10W</td><td align="center" valign="middle">10</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">8</td><td align="center" valign="middle">S</td><td align="center" valign="middle">none</td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAE12U</td><td align="center" valign="middle">10</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">8</td><td align="center" valign="middle">S</td><td align="center" valign="middle">none</td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAI10Z</td><td align="center" valign="middle">Novel</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">4</td><td align="center" valign="middle">S</td><td align="center" valign="middle"><italic>catA1, catB4</italic></td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAM10K</td><td align="center" valign="middle">443</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">4</td><td align="center" valign="middle">S</td><td align="center" valign="middle"><italic>catA1</italic></td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAJ10A</td><td align="center" valign="middle">131</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">4</td><td align="center" valign="middle">S</td><td align="center" valign="middle">none</td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAC13M</td><td align="center" valign="middle">44</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">4</td><td align="center" valign="middle">S</td><td align="center" valign="middle">none</td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAF11G</td><td align="center" valign="middle">15</td><td align="center" valign="middle"><italic>KpSC</italic></td><td align="center" valign="middle">512</td><td align="center" valign="middle">R</td><td align="center" valign="middle"><italic>catA1, catB4, cmlA5</italic></td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAC11N</td><td align="center" valign="middle">45</td><td align="center" valign="middle"><italic>KpSC</italic></td><td align="center" valign="middle">&gt;512</td><td align="center" valign="middle">R</td><td align="center" valign="middle"><italic>catA2, catB4, cmlA5</italic></td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAE12L</td><td align="center" valign="middle">340</td><td align="center" valign="middle"><italic>KpSC</italic></td><td align="center" valign="middle">&gt;512</td><td align="center" valign="middle">R</td><td align="center" valign="middle"><italic>catA2, cmlA5</italic></td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAE135</td><td align="center" valign="middle">340</td><td align="center" valign="middle"><italic>KpSC</italic></td><td align="center" valign="middle">&gt;512</td><td align="center" valign="middle">R</td><td align="center" valign="middle"><italic>catA2</italic>, <italic>cmlA5</italic></td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAB15M</td><td align="center" valign="middle">152</td><td align="center" valign="middle"><italic>KpSC</italic></td><td align="center" valign="middle">256</td><td align="center" valign="middle">R</td><td align="center" valign="middle"><italic>catA1, catB4</italic></td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAC13Y</td><td align="center" valign="middle">307</td><td align="center" valign="middle"><italic>KpSC</italic></td><td align="center" valign="middle">64</td><td align="center" valign="middle">R</td><td align="center" valign="middle"><italic>catB4</italic></td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAF102</td><td align="center" valign="middle">15</td><td align="center" valign="middle"><italic>KpSC</italic></td><td align="center" valign="middle">8</td><td align="center" valign="middle">S</td><td align="center" valign="middle"><italic>catB4</italic></td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAC14G</td><td align="center" valign="middle">1427</td><td align="center" valign="middle"><italic>KpSC</italic></td><td align="center" valign="middle">8</td><td align="center" valign="middle">S</td><td align="center" valign="middle"><italic>catB4</italic></td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAB16G</td><td align="center" valign="middle">14</td><td align="center" valign="middle"><italic>KpSC</italic></td><td align="center" valign="middle">4</td><td align="center" valign="middle">S</td><td align="center" valign="middle"><italic>catB4</italic></td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAC105</td><td align="center" valign="middle">307</td><td align="center" valign="middle"><italic>KpSC</italic></td><td align="center" valign="middle">4</td><td align="center" valign="middle">S</td><td align="center" valign="middle"><italic>catB4</italic></td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAC13D</td><td align="center" valign="middle">340</td><td align="center" valign="middle"><italic>KpSC</italic></td><td align="center" valign="middle">4</td><td align="center" valign="middle">S</td><td align="center" valign="middle"><italic>catB4</italic></td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAG19R</td><td align="center" valign="middle">1427</td><td align="center" valign="middle"><italic>KpSC</italic></td><td align="center" valign="middle">4</td><td align="center" valign="middle">S</td><td align="center" valign="middle"><italic>catB4</italic></td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAD137</td><td align="center" valign="middle">14</td><td align="center" valign="middle"><italic>KpSC</italic></td><td align="center" valign="middle">4</td><td align="center" valign="middle">S</td><td align="center" valign="middle">none</td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">CAL11H</td><td align="center" valign="middle">307</td><td align="center" valign="middle"><italic>KpSC</italic></td><td align="center" valign="middle">4</td><td align="center" valign="middle">S</td><td align="center" valign="middle">none</td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">CAD107</td><td align="center" valign="middle">14</td><td align="center" valign="middle"><italic>KpSC</italic></td><td align="center" valign="middle">2</td><td align="center" valign="middle">S</td><td align="center" valign="middle">none</td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">MG1655</td><td align="center" valign="middle">-</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">&gt;512</td><td align="center" valign="middle">R</td><td align="center" valign="middle">pEB1-<italic>catA1</italic></td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">MG1655</td><td align="center" valign="middle">-</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">&gt;512</td><td align="center" valign="middle">R</td><td align="center" valign="middle">pEB1-<italic>catA2</italic></td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">MG1655</td><td align="center" valign="middle">-</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">&gt;512</td><td align="center" valign="middle">R</td><td align="center" valign="middle">pEB1-<italic>catB3</italic></td></tr><tr style="background-color:#CECBCE"><td align="center" valign="middle">MG1655</td><td align="center" valign="middle">-</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">8</td><td align="center" valign="middle">S</td><td align="center" valign="middle">pEB1-<italic>catB4</italic></td></tr><tr style="background-color:#FFFFFF"><td align="center" valign="middle">MG1655</td><td align="center" valign="middle">-</td><td align="center" valign="middle"><italic>E. coli</italic></td><td align="center" valign="middle">8</td><td align="center" valign="middle">S</td><td align="center" valign="middle">none</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P48">ID = name/identifier of isolate, ST = sequence type, CHL = chloramphenicol, MIC = minimal inhibitory concentration (in μg/mL). R = resistant, S = susceptible.</p></fn></table-wrap-foot></table-wrap></floats-group></article>